NewAmsterdam Pharma Company N.V.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2023 | $-31.9M | $-31.9M | $7.0K | $7.6M |
| Jun 2023 | $-29.3M | $-29.3M | $5.0K | $5.6M |
| Sep 2023 | $-47.0M | $-47.0M | $9.0K | $5.4M |
| Dec 2023 | $-33.1M | $-33.1M | $3.0K | $6.0M |
| Mar 2024 | $-54.6M | $-55.0M | $385.0K | $7.9M |
| Jun 2024 | $-54.0M | $-54.2M | $209.0K | $8.3M |
| Sep 2024 | $-12.5M | $-12.6M | $75.0K | $8.0M |
| Dec 2024 | $-37.5M | $-37.5M | $3.0K | $9.4M |
| Mar 2025 | $-36.5M | $-36.5M | $16.0K | $15.2M |
| Jun 2025 | $-37.7M | $-37.8M | $88.0K | $15.2M |
| Sep 2025 | $-32.8M | $-32.8M | $42.0K | $15.0M |
| Dec 2025 | $-40.9M | $-41.0M | $100.0K | $14.0M |
| Mar 2026 | $-30.6M | $-30.6M | $38.0K | $18.0M |
| Jun 2026 | $-39.2M | $-39.3M | $80.0K | $18.4M |